This compound is an active pharmaceutical ingredient, a synthetic vitamin D analog with a secosteroid structure. It is characterized by a trans-configured cyclohexanediol moiety and multiple stereocenters, and is supplied for pharmaceutical manufacturing and research purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 74007-20-8
Calcipotriene hydrate
pharmaceutical raw material
1,25-dihydroxycalciferol
pharmaceutical raw material
Hydrocortisone aceponate
pharmaceutical raw material
Haloperidol decanoate
pharmaceutical raw material
Ketanserin
pharmaceutical raw material
Ketorolac
pharmaceutical raw material
(1R,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
Impurity of Doxercalciferol
Doxercalciferol
pharmaceutical raw material
trans-(1R,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
HKXBNHCUPKIYDM-HBZIUUSASA-N
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C\3/C[C@H](C[C@@H](C3=C)O)O)C